Description: This analytical blend combines a selective Growth Hormone Secretagogue (Ipamorelin) with a GHRH analog (CJC-1295). The combination is designed to examine the dual-pathway stimulation of the pituitary gland. It is utilized in research to observe the amplification of endogenous growth hormone pulses without the extended half-life provided by a Drug Affinity Complex.